Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
申请人:Favor David
公开号:US20060234997A1
公开(公告)日:2006-10-19
Compounds of formula 1
are disclosed, wherein G, D, A, Q, Y, Z, and R
1
through R
10
are defined in the specification. Also provided are descriptions of processes for preparing compounds of formula 1, intermediates used in making the same, and pharmaceutical compositions containing such compounds and their use in the treatment of central nervous system disorders and other disorders.